找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Glaucoma Drainage Devices; A Practical Illustra Monica Gandhi,Shibal Bhartiya Book 2019 Springer Nature Singapore Pte Ltd. 2019 Surgical te

[復(fù)制鏈接]
樓主: OAK
31#
發(fā)表于 2025-3-26 23:41:19 | 只看該作者
32#
發(fā)表于 2025-3-27 04:10:28 | 只看該作者
33#
發(fā)表于 2025-3-27 08:15:49 | 只看該作者
34#
發(fā)表于 2025-3-27 11:10:05 | 只看該作者
https://doi.org/10.1007/978-3-662-48417-3tained on maximally tolerable medical therapy and glaucomatous damage is still progressing or is deemed likely to progress, then surgery is suggested to the patient. Usually, the surgeon and the patient are faced with a dilemma to choose between a trabeculectomy and a glaucoma drainage device.
35#
發(fā)表于 2025-3-27 14:29:55 | 只看該作者
36#
發(fā)表于 2025-3-27 21:02:59 | 只看該作者
https://doi.org/10.1007/978-3-662-12009-5irreversible blindness. Therefore management of IOP may be required before, along with or after the patient has undergone PKP. Irreversible visual loss is seen due to optic nerve damage, and graft failure is caused by persistent rise in IOP leading to chronic corneal endothelial damage leading to corneal oedema and compromised graft clarity [1].
37#
發(fā)表于 2025-3-27 22:06:08 | 只看該作者
Ettore Majorana International Science Seriesprimary surgery of choice in refractory glaucomas like post-penetrating keratoplasty glaucoma, glaucoma following retinal surgery, neovascular glaucoma, and irido-corneal endothelial syndrome and in patients with scarred conjunctiva. They are frequently used in cases with failed trabeculectomy surgery also.
38#
發(fā)表于 2025-3-28 05:58:08 | 只看該作者
Preparing the Patient for the Glaucoma Drainage Device Surgery,tained on maximally tolerable medical therapy and glaucomatous damage is still progressing or is deemed likely to progress, then surgery is suggested to the patient. Usually, the surgeon and the patient are faced with a dilemma to choose between a trabeculectomy and a glaucoma drainage device.
39#
發(fā)表于 2025-3-28 08:10:13 | 只看該作者
40#
發(fā)表于 2025-3-28 10:45:29 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 03:11
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
宁晋县| 肇庆市| 巴林右旗| 晋城| 甘孜县| 彭阳县| 江门市| 三江| 武川县| 舟山市| 特克斯县| 枝江市| 云浮市| 馆陶县| 胶州市| 吉隆县| 古田县| 巴南区| 错那县| 峨边| 元江| 永善县| 遵义县| 闵行区| 龙泉市| 铜山县| 青浦区| 萝北县| 新民市| 瑞昌市| 元氏县| 潜山县| 彭泽县| 武平县| 沅陵县| 普安县| 金阳县| 成都市| 安化县| 伊春市| 方正县|